Axsome Therapeutics, Inc. (AXSM)
NASDAQ · Healthcare
Axsome Therapeutics, Inc. annual/quarterly cash on hand history from 2022 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Axsome Therapeutics, Inc. cash on hand for the quarter ending December 31, 2025 were 322.9M, a 2.40% increase year-over-year.
- Axsome Therapeutics, Inc. cash on hand for 2025 were 322.9M, a 2.40% increase from 2024.
- Axsome Therapeutics, Inc. cash on hand for 2024 were 315.4M, a 18.34% decrease from 2023.
- Axsome Therapeutics, Inc. cash on hand for 2023 were 386.2M, a 92.29% increase from 2022.
- Axsome Therapeutics, Inc. cash on hand for 2022 were 200.8M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Axsome Therapeutics, Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $323 |
| 2024 | $315 |
| 2023 | $386 |
| 2022 | $201 |
| Axsome Therapeutics, Inc. Quarterly Cash on Hand (Millions of US $) | |
|---|---|
| 2025-12-31 | $323 |
| 2024-12-31 | $315 |
| 2023-12-31 | $386 |
| 2022-12-31 | $201 |
Axsome Therapeutics, Inc. Cash on Hand — FAQ
Axsome Therapeutics, Inc. (AXSM) cash on hand over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AXSM's cash on hand history?
The chart and table above show Axsome Therapeutics, Inc.'s cash on hand by year and by quarter, including the growth rate.